New drug trial targets deadly prostate cancer variant
Disease control
Not yet recruiting
This study is testing an experimental pill called zanzalintinib for men with a particularly aggressive and difficult-to-treat form of advanced prostate cancer that has spread. The main goal is to see if the drug can slow or stop the cancer's growth and improve survival. About 30 …
Phase: PHASE2 • Sponsor: Deepak Kilari • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC